Page 164 - Human Bile Acid Metabolism: a Postprandial Perspective

Chapter 8
68. Broeders EPM, Nascimento EBM, Havekes B, et al. The bile acid chenodeoxycholic acid increases
human brown adipose tissue activity. Cell Metab 2015; 22: 418−26.
69. Langeveld M, Tan CY, Soeters M, et al. Mild cold effects on hunger, food intake, satiety and skin
temperature in humans. Endocr Connect 2016; 5: 65−73.
70. Ockenga J, Valentini L, Schuetz T, et al. Plasma bile acids are associated with energy expenditure and
thyroid function in humans. J Clin Endocrinol Metab 2012; 97: 535−42.
71. Brufau G, Bahr MJ, Staels B, et al. Plasma bile acids are not associated with energy metabolism in
humans. Nutr Metab (Lond) 2010; 7: 73.
72. Benedetti G, Mingrone G, Marcoccia S, et al. Body composition and energy expenditure after weight
loss following bariatric surgery. J Am Coll Nutr 2000; 9: 270−74.
73. Kohli R, Bradley D, Setchell KD, Eagon JC, Abumrad N, Klein S. Weight loss induced by Roux-en-Y gastric bypass but not laparoscopic adjustable gastric banding increases circulating bile acids. J Clin Endocrinol Metab 2013; 98: E708−12.
74. Werling M, Olbers T, Fandriks L, et al. Increased postprandial energy expenditure may explain superior long term weight loss after Roux-en-Y gastric bypass compared to vertical banded gastroplasty. PLoS One 2013; 8: e60280.
75. Eggink HM, Soeters MR, Pols TW. TGR5 ligands as potential therapeutics in inflammatory diseases. Int J Interfer Cytokine Med Res 2014; 6: 27−38.
76. Pols TW. TGR5 in inflammation and cardiovascular disease. Biochem Soc Trans 2014; 42: 244−49.
77. Fiorucci S, Cipriani S, Mencarelli A, Renga B, Distrutti E, Baldelli F. Counter-regulatory role of bile
acid activated receptors in immunity and inflammation. Curr Mol Med 2010; 10: 579−95.
78. Wang YD, Chen WD, Yu D, Forman BM, Huang W. The G-protein-coupled bile acid receptor, Gpbar1 (TGR5), negatively regulates hepatic inflammatory response through antagonizing nuclear factor kappa light-chain enhancer of activated B cells (NF-kappaB) in mice. Hepatology 2011; 54: 1421−32.
79. Péan N, Doignon I, Garcin I, et al. The receptor TGR5 protects the liver from bile acid overload during liver regeneration in mice. Hepatology 2013; 58: 1451−60.
80. Lou G, Ma X, Fu X, et al. GPBAR1/TGR5 mediates bile acid-induced cytokine expression in murine Kupffer cells. PLoS One 2014; 9: 1−10.
81. Haselow K, Bode JG, Wammers M, et al. Bile acids PKA-dependently induce a switch of the IL-10/ IL-12 ratio and reduce proinflammatory capability of human macrophages. J Leukoc Biol 2013; 94: 1253−64.
82. Hogenauer K, Arista L, Schmiedeberg N, et al. G-protein-coupled bile acid receptor 1 (GPBAR1, TGR5) agonists reduce the production of proinflammatory cytokines and stabilize the alternative macrophage phenotype. J Med Chem 2014; 57: 10343−54.
83. Ichikawa R, Takayama T, Yoneno K, et al. Bile acids induce monocyte differentiation toward interleukin-12 hypo-producing dendritic cells via a TGR5-dependent pathway. Immunology 2012; 136: 153−62.
84. Mobraten K, Haugbro T, Karlstrom E, Kleiveland CR, Lea T. Activation of the bile acid receptor TGR5 enhances LPS-induced inflammatory responses in a human monocytic cell line. J Recept Signal Transduct Res 2015; 35: 402−09.
85. Perino A, Pols TW, Nomura M, Stein S, Pellicciari R, Schoonjans K. TGR5 reduces macrophage migration through mTOR-induced C/EBPbeta differential translation. J Clin Invest 2014; 124: 5424−36.
86. Cipriani S, Mencarelli A, Chini MG, et al. The bile acid receptor GPBAR-1 (TGR5) modulates integrity of intestinal barrier and immune response to experimental colitis. PLoS One 2011; 6: e25637.
87. Yoneno K, Hisamatsu T, Shimamura K, et al. TGR5 signalling inhibits the production of pro- inflammatory cytokines by in vitro differentiated inflammatory and intestinal macrophages in Crohn’s disease. Immunology 2013; 139: 19−29.
88. Hov JR, Keitel V, Schrumpf E, Häussinger D, Karlsen TH. TGR5 sequence variation in primary sclerosing cholangitis. Dig Dis 2011; 29: 78−84.
89. Nappo F, Esposito K, Cioffi M, et al. Postprandial endothelial activation in healthy subjects and in type 2 diabetic patients: role of fat and carbohydrate meals. J Am Coll Cardiol 2002; 39: 1145−50.
162